Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report
CONCLUSION: The clinical outcome of this case supports the conclusion of previously published reports, summarized here within, demonstrating that HIV-1 positive status should not preclude HT in carefully selected individuals. Both addressing potential DDIs prior to HT and long-term monitoring for routine post-transplant complications and secondary and incidental malignancies are imperative.PMID:37568163 | PMC:PMC10422718 | DOI:10.1186/s12981-023-00551-x
Source: AIDS Research and Therapy - Category: Infectious Diseases Authors: Thamer A Almangour Preston T Skersick Amanda Corbett Jo E Rodgers Patricia P Chang Claire E Farel Source Type: research
More News: Adenocarcinoma | Basal Cell Carcinoma | Bone Graft | Brain | Cancer & Oncology | Carcinoma | Cardiology | Cardiomyopathy | Heart | Heart Failure | Heart Transplant | HIV AIDS | Infectious Diseases | Isentress | Neurology | Peripheral Neuropathy | Prograf | Skin Cancer | Tacrolimus | Transplant Surgery | Transplants | Truvada | Viread